#1 - UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Inc. (NYSE: UNH) is one of the largest healthcare stocks by market capitalization. The company is best known as a leader in managed care, but it also owns the Optum network which is helping to deliver analytics-based, affordable healthcare.
UNH stock has also been one of the best performers in the past 10 years, with a total return of over 685%. However, past performance isn’t a reliable indicator of future growth. There’s a reason why analysts are still bullish on the company. UnitedHealth recently acquired LHC Group, which will expand the company’s reach into the growing home healthcare business.
Anyone who has managed the needs of an elderly parent knows this is an area of the economy that will get larger, not smaller. This acquisition positions UnitedHealth to be a significant player in the space.
Plus, investors get a dividend that has been increasing at an average annual rate of over 14% in the last three years, that’s more than four times the current rate of inflation.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More - Current Price
- $575.02
- Consensus Rating
- Buy
- Ratings Breakdown
- 19 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $614.17 (6.8% Upside)
